Sarepta Therapeutics | SRPT - Текущие активы





Текущие активы Изменить Дата
Acadia Pharmaceuticals USD 1.1B 33.9M 2026-03
Agios Pharmaceuticals USD 717.67M 117.18M 2026-06
Alnylam Pharmaceuticals USD 4.62B 400.86M 2026-06
Amgen USD 31.48B 2.42B 2026-03
BioCryst Pharmaceuticals USD 373.62M 30.72M 2026-03
Biogen USD 7.31B 1.88B 2026-06
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Capricor Therapeutics USD 283.09M 39.85M 2026-03
Daiichi Sankyo JPY 2.23T 91.92B 2026-06
Eli Lilly USD 54.84B 794M 2026-03
Gilead Sciences USD 18.64B 1.25B 2026-03
Incyte USD 6.03B 542.31M 2026-06
Insmed USD 1.61B 181.04M 2026-03
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
Moderna USD 5.82B 45M 2026-06
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Neurocrine Biosciences USD 1.64B 798.6M 2026-06
Novavax USD 850.82M 127.46M 2026-03
Pfizer USD 42.82B 76M 2026-03
PTC Therapeutics USD 2.62B 363.36M 2026-06
Regeneron Pharmaceuticals USD 18.45B 236.8M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sanofi EUR 31.52B 1.36B 2026-06
Sarepta Therapeutics USD 2.31B 228.06M 2026-03
Tectonic Therapeutic USD 239.89M 17.47M 2026-03
Ultragenyx Pharmaceutical USD 657M 294M 2026-03
Vertex Pharmaceuticals USD 11.73B 529.3M 2026-03